Liedtke, Michaela
Stanford Medicine · Stanford University
6 papers on CoChatORCID 0000-0001-8945-5850
Most cited papers
- Verified
Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma.
Raje, N., Berdeja, J., Lin, Y., Siegel, D., Jagannath, S., Madduri, D., Liedtke, M., Rosenblatt, J., Maus, M. V., Turka, A., et al. (2019) · New England Journal of Medicine
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 1,730
- Verified
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
Gandhi, U. H., Cornell, R. F., Lakshman, A., Gahvari, Z. J., McGehee, E., Jagosky, M. H., Gupta, R., Varnado, W., Fiala, M. A., Chhabra, S., et al. (2019) · Leukemia
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 616
- Verified
Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia
Granja, J. M., Klemm, S., McGinnis, L. M., Kathiria, A. S., Mezger, A., Corces, M. R., Parks, B., Gars, E., Liedtke, M., Zheng, G. X. Y., et al. (2019) · Nature Biotechnology
Single-cell and spatial transcriptomicsGenomics and Chromatin Dynamics
Cited by 498
- Verified
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Richardson, P. G., Jacobus, S. J., Weller, E. A., Hassoun, H., Lonial, S., Raje, N. S., Medvedova, E., McCarthy, P. L., Libby, E. N., Voorhees, P. M., et al. (2022) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 487
- Verified
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Gasparetto, C., et al. (2017) · Journal of the National Comprehensive Cancer Network
Multiple Myeloma Research and TreatmentsAmyloidosis: Diagnosis, Treatment, Outcomes
Cited by 279
- Verified
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Mailankody, S., Matous, J. V., Chhabra, S., Liedtke, M., Sidana, S., Oluwole, O. O., Malik, S., Nath, R., Anwer, F., Cruz, J. C., et al. (2023) · Nature Medicine
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 257
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free